Pharmacogenetics of Gilbert‘s Syndrome
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Gilbert's syndrome is characterized by mild unconjugated nonhemolytic hyperbilirubinemia, which does not lead to hepatic inflammation, fibrosis, chronic liver disease or liver failure. Almost 100 years after its clinical description, it was linked to a genetic variant of the human bilirubin UDP-glucuronosyltransferase (UGT1A1), UGT1A1 (*)28, found in approximately 40% of Caucasoid individuals. Over 113 UGT1A1 variants have since been reported, leading to a continuous spectrum from mild hyperbilirubinemia to life-threatening jaundice. UGT1A variants are evolutionary diverse and occur in the context of haplotypes combining different variants within the promoter, the 5 exons, as well as introns of the UGT1A1 gene, and also in combination with other UGT1A genes expressed in the liver and the extrahepatic gastrointestinal tract. The variation of glucuronidation hidden behind Gilbert's syndrome impacts drug therapy, which includes the well-characterized examples of irinotecan and atazanavir. The prediction of unwanted drug reactions associated with Gilbert's syndrome will improve drug safety, therapeutic individualization and impact the drug-development process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Douillard, J., Cunningham, D., Roth, A., Navarro, M., James, R., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02034-1 · Cited by 3,256
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
Prueksaritanont, T., Subramanian, R., Fang, X., Ma, B., Qiu, Y., Lin, J. H., Pearson, P. G., & Baillie, T. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.5.505 · Cited by 344 · cited 2×
“Simvastatin, atorvastatin, cerivastatin* [65]”
Background
Cited by
Digital Quantification of Human Eye Color Highlights Genetic Association of Three New Loci
Liu, F., Wollstein, A., Hysi, P. G., Ankra-Badu, G. A., Spector, T. D., Park, D., Zhu, G., Larsson, M., Duffy, D. L., Montgomery, G. W., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000934 · Cited by 191
“Variants in this gene influence bilirubin plasma levels [26], and were suggested to cause Gilbert’s syndrome [27], which is the most common syndrome known in humans characterized with mild and harmless jaundice characterized by a yellowish discoloration of the skin.”
BackgroundKalthoff, S., Ehmer, U., Freiberg, N., Manns, M. P., & Strassburg, C. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.048 · Cited by 124
Self-citationJacobs, L. C., Wollstein, A., Lao, O., Hofman, A., Klaver, C. C., Uitterlinden, A. G., Nijsten, T., Kayser, M., & Liu, F. (2013) · Human Genetics · doi:10.1007/s00439-012-1232-9 · Cited by 99
“Allele frequencies of UGT1A variants for example, vary across different populations (Strassburg 2008), but the GATA3 variants seem more stable in different populations (Supplementary table 4).”
Background(2009) · PubMed · Cited by 26
Complex Gene−Chemical Interactions: Hepatic Uroporphyria As a Paradigm
Smith, A. G., & Elder, G. H. (2010) · Chemical Research in Toxicology · doi:10.1021/tx900298k · Cited by 20
Metadata
- Authors
- Strassburg, C. P.
- Venue
- Pharmacogenomics
- Publisher
- Informa UK Limited
- Published
- 2008-06
- Volume
- 9
- Issue
- 6
- Pages
- 703-715
- ISSN
- 1462-2416 (ISSN-L)
- 1744-8042
- OpenAlex
- W2164564169
- Cited by
- 165
- References
- 2
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacogenetics of Gilbert‘s Syndrome. https://app.cochat.ai/papers/10.2217/14622416.9.6.703
- The paper
- Strassburg, C. P. (2008). Pharmacogenetics of Gilbert‘s Syndrome. Pharmacogenomics. https://doi.org/10.2217/14622416.9.6.703
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.